An update on novel oral anticoagulants

Research output: Contribution to journalArticlepeer-review


Stroke is the leading cause of bedridden and dependent patients worldwide. Since cardioembolic stroke, the most severe subtype of ischemic stroke, often develops in subjects with atrial fibrillation, optimal anticoagulation therapy should be administered to those with atrial fibrillation, particularly in the elderly. Recently, several novel oral anticoagulants(NOAC)have been developed for the prevention of cardioembolic stroke. Accordingly, it is important to have thorough understanding of these NOACs, including both their individual characteristics and their proper administration protocols. In this review, we discuss the present status and cautionary notes for using anticoagulation therapy in the prevention of cardioembolic stroke.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalJapanese Journal of Neurosurgery
Issue number4
Publication statusPublished - 2015

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'An update on novel oral anticoagulants'. Together they form a unique fingerprint.

Cite this